1. P144 Impact of major medication discontinuation during the first wave of COVID-19 pandemic on the risk of early relapse in patients with inflammatory bowel disease: a French observational retrospective study. (30th January 2023) Authors: Meunier, C; Monte, C; Hadjisavvas, H; Rozieres, A; Roblin, X; Venturin, C; Gay, C; Flourie, B; Boschetti, G; Danion, P; Mathieu, N; Charlois, A L; Faure, M; Nancey, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P618 Vedolizumab acute infusion reactions in inflammatory bowel disease patients: results of a multi-centre retrospective observational cohort study. (25th January 2019) Authors: Venturin, C; Nancey, S; Roblin, X; Peyrin-Biroulet, L; Mathieu, N; Flourié, B; Boschetti, G Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗